# FDA Inspection 680212 - Lymol Medical Corporation - September 14, 2010

Source: https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/31198594-7c5f-4234-a6f4-7d3e88a17eca
Source feed: FDA_Inspections

> FDA Inspection 680212 for Lymol Medical Corporation on September 14, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 680212
- Company Name: Lymol Medical Corporation
- Inspection Date: 2010-09-14
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1147369 - 2021-07-29](https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/7392a612-994e-427e-bbe8-61ba5300ed8d)
- [FDA Inspection 1117620 - 2020-02-12](https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/933ff1ee-2777-4d54-9b0c-e5dc8212dcb1)
- [FDA Inspection 1117620 - 2020-02-12](https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/c53e87fb-c46e-4dee-aa5b-322d5acd9a99)
- [FDA Inspection 976447 - 2016-06-24](https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/162fdcce-9c78-4596-868b-4d3df5304424)
- [FDA Inspection 976447 - 2016-06-24](https://www.globalkeysolutions.net/records/fda_inspections/lymol-medical-corporation/ec8f4d44-25fd-4a65-9a46-595698c6d49d)

Company: https://www.globalkeysolutions.net/companies/lymol-medical-corporation/a98bac62-27b5-4afb-897b-aed3e10e1d9c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c